ICL Group Ltd. reported total sales of $1.8 billion for Q2 2025, with an adjusted EBITDA of $351 million and an adjusted diluted EPS of $0.09. The company experienced an 8% year-over-year increase in specialties-driven sales and maintained stable performance despite ongoing war-related issues.